Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Metsera Inc. stock logo
MTSR
Metsera
$70.50
-0.4%
$64.53
$12.30
$83.86
$7.42BN/A4.84 million shs27.90 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.08
-0.2%
$25.21
$23.11
$28.75
$142.77B0.3547.46 million shs45.60 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Metsera Inc. stock logo
MTSR
Metsera
0.00%0.00%0.00%0.00%+61.22%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+3.57%-0.69%-9.06%+2.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Metsera Inc. stock logo
MTSR
Metsera
$70.50
-0.4%
$64.53
$12.30
$83.86
$7.42BN/A4.84 million shs27.90 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.08
-0.2%
$25.21
$23.11
$28.75
$142.77B0.3547.46 million shs45.60 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Metsera Inc. stock logo
MTSR
Metsera
0.00%0.00%0.00%0.00%+61.22%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+3.57%-0.69%-9.06%+2.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Metsera Inc. stock logo
MTSR
Metsera
2.20
Hold$53.67-23.88% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.19
Hold$28.5013.64% Upside

Current Analyst Ratings Breakdown

Latest MTSR and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/13/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetOutperform$34.00 ➝ $30.00
7/13/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetBuy$36.00 ➝ $35.00
7/10/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetNeutral$27.00 ➝ $26.00
7/8/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetNeutral$30.00 ➝ $28.00
7/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
DowngradeBuyHold$32.00 ➝ $28.00
7/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingNeutral$27.00
6/23/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingOutperform
6/9/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeUnderperformSector Perform$25.00
6/1/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingNeutral
5/27/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingNeutral$27.00
(Data available from 7/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Metsera Inc. stock logo
MTSR
Metsera
N/AN/AN/AN/A$3.20 per shareN/A
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.28$4.40 per share5.70$15.26 per share1.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Metsera Inc. stock logo
MTSR
Metsera
-$209.13M-$6.32N/AN/AN/AN/A-121.12%-53.54%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.158.80N/A11.83%19.44%8.41%8/4/2026 (Estimated)

Latest MTSR and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.68N/AN/AN/A$14.42 billionN/A
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Metsera Inc. stock logo
MTSR
Metsera
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.86%-13.20%131.30%16 Years

Latest MTSR and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/24/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.15%7/24/20267/24/20269/1/2026
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Metsera Inc. stock logo
MTSR
Metsera
N/A
4.25
5.26
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94

Institutional Ownership

CompanyInstitutional Ownership
Metsera Inc. stock logo
MTSR
Metsera
N/A
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Metsera Inc. stock logo
MTSR
Metsera
N/A
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Metsera Inc. stock logo
MTSR
Metsera
81105.29 millionN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Pfizer Inc. $PFE Shares Bought by Swiss National Bank
Pfizer Inc. $PFE Stock Position Raised by AIA Group Ltd
Erste Group Bank Decreases Earnings Estimates for Pfizer
Pfizer Stock Near Lows But Analysts See Upside Ahead
Can Pfizer (NYSE:PFE) Strengthen Its Pipeline Story?
3 High-Yield Dividend Stocks to Buy and Hold
Pfizer (NYSE:PFE) Shares Sold Off Sen. Tommy Tuberville

New MarketBeat Followers Over Time

Media Sentiment Over Time

Metsera stock logo

Metsera NASDAQ:MTSR

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell in 2022 and is headquartered in New York.

Pfizer stock logo

Pfizer NYSE:PFE

$25.08 -0.06 (-0.24%)
Closing price 07/17/2026 03:59 PM Eastern
Extended Trading
$25.06 -0.01 (-0.06%)
As of 07/17/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.